We must not wait idly for an elusive COVID-19 vaccine

Behavioural and drug-based interventions will save lives and better prepare us for the next crisis. After more than three decades of research and billions of dollars spent, the Malaria vaccine still offers just modest efficacy — will the coronavirus vaccine share the same fate? The director of the Global Health Group at the University of California in San Francisco, Richard Feachem, contemplates for the Financial Times.